SM200000031B - Prolonged effect antiangiogenic peptides - Google Patents
Prolonged effect antiangiogenic peptidesInfo
- Publication number
- SM200000031B SM200000031B SM200000031A SM200000031A SM200000031B SM 200000031 B SM200000031 B SM 200000031B SM 200000031 A SM200000031 A SM 200000031A SM 200000031 A SM200000031 A SM 200000031A SM 200000031 B SM200000031 B SM 200000031B
- Authority
- SM
- San Marino
- Prior art keywords
- prolonged effect
- antiangiogenic peptides
- peptides
- effect antiangiogenic
- prolonged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13440699P | 1999-05-17 | 1999-05-17 | |
PCT/IB2000/000763 WO2000070665A2 (en) | 1999-05-17 | 2000-05-17 | Long lasting anti-angiogenic peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
SM200000031B true SM200000031B (en) | 2001-11-21 |
SM200000031A SM200000031A (en) | 2001-11-21 |
Family
ID=22463240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM200000031A SM200000031A (en) | 1999-05-17 | 2000-10-09 | Prolonged effect antiangiogenic peptides |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1171582A2 (en) |
JP (3) | JP4209086B2 (en) |
CN (2) | CN1698881A (en) |
AU (1) | AU764103B2 (en) |
CA (1) | CA2373252C (en) |
SM (1) | SM200000031A (en) |
TW (1) | TWI300414B (en) |
WO (1) | WO2000070665A2 (en) |
ZA (2) | ZA200106676B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002239414A1 (en) * | 2000-11-02 | 2002-05-27 | Bristol-Myers Squibb Company | Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
DE60226702D1 (en) | 2001-02-16 | 2008-07-03 | Conjuchem Biotechnologies Inc | LONG ACTING GLUCAGON-SIMILAR PEPTIDE-2 FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS |
DE60229677D1 (en) | 2001-05-31 | 2008-12-11 | Conjuchem Biotechnologies Inc | Long acting fusion peptide inhibitors against HIV infection |
CA2488348A1 (en) * | 2002-07-31 | 2004-02-05 | Conjuchem Inc. | Long lasting natriuretic peptide derivatives |
EA007918B1 (en) * | 2002-09-24 | 2007-02-27 | Франтиэ Биотекнолоджиз Ко., Лтд. | Peptide derivatives fusion inhibitors of hiv infection |
CN103897031A (en) * | 2012-12-25 | 2014-07-02 | 深圳先进技术研究院 | Chemically modified thymopentin and synthetic method thereof |
CN104892725A (en) * | 2015-05-19 | 2015-09-09 | 广州诺威生物技术有限公司 | Novel naphthalene acetamide compound |
CN109503700A (en) * | 2017-09-14 | 2019-03-22 | 南京安吉生物科技有限公司 | The blood vessel formation inhibitor IIM 3-1 of maleimide base group modification and its application |
CN110372781B (en) * | 2019-07-29 | 2021-11-16 | 深圳佳肽生物科技有限公司 | Preparation method and application of Enfuvirtide |
CN117186187B (en) * | 2023-07-12 | 2024-05-31 | 中国医学科学院病原生物学研究所 | Anti-respiratory syncytial virus membrane fusion inhibitor and pharmaceutical application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0602290B1 (en) * | 1992-12-04 | 1999-08-25 | ConjuChem, Inc. | Antibody-conjugated Hepatitis B surface antigen and use thereof |
NZ330537A (en) * | 1995-12-13 | 2001-06-29 | Childrens Medical Center | Kringle 5 rerion of plasminogen as an endothelial cell proliferation inhibitor |
DE69733756T2 (en) * | 1996-05-03 | 2006-06-01 | Abbott Laboratories, Abbott Park | ANTIANGIOGENIC PEPTIDES, POLYNUCLEOTIDES THAT CODE AND METHODS OF INHIBITING ANGIOGENESIS |
ES2173641T3 (en) * | 1997-11-07 | 2002-10-16 | Conjuchem Inc | COMPOSITION OF OPIACE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES. |
CA2628053A1 (en) * | 1997-11-07 | 1999-05-20 | Conjuchem Biotechnologies Inc. | Affinity markers for human serum albumin |
AU748496B2 (en) * | 1998-03-23 | 2002-06-06 | Conjuchem, Inc. | Local delivery of long lasting therapeutic agents |
GB9815505D0 (en) * | 1998-07-16 | 1998-09-16 | Adprotech Plc | Polypeptide derivatives |
-
2000
- 2000-05-17 CA CA002373252A patent/CA2373252C/en not_active Expired - Fee Related
- 2000-05-17 CN CNA2005100059909A patent/CN1698881A/en active Pending
- 2000-05-17 JP JP2000619018A patent/JP4209086B2/en not_active Expired - Fee Related
- 2000-05-17 WO PCT/IB2000/000763 patent/WO2000070665A2/en active IP Right Grant
- 2000-05-17 AU AU47748/00A patent/AU764103B2/en not_active Ceased
- 2000-05-17 EP EP00929748A patent/EP1171582A2/en not_active Withdrawn
- 2000-05-17 CN CNA2008100915043A patent/CN101289500A/en active Pending
- 2000-06-19 TW TW094112549A patent/TWI300414B/en not_active IP Right Cessation
- 2000-10-09 SM SM200000031A patent/SM200000031A/en unknown
-
2001
- 2001-08-14 ZA ZA200106676A patent/ZA200106676B/en unknown
- 2001-11-05 ZA ZA200109110A patent/ZA200109110B/en unknown
-
2008
- 2008-01-17 JP JP2008008554A patent/JP2008110986A/en not_active Withdrawn
-
2009
- 2009-02-03 JP JP2009023118A patent/JP2009143941A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TW200524957A (en) | 2005-08-01 |
WO2000070665A3 (en) | 2001-04-19 |
AU4774800A (en) | 2000-12-05 |
AU764103B2 (en) | 2003-08-07 |
EP1171582A2 (en) | 2002-01-16 |
ZA200106676B (en) | 2002-07-19 |
CA2373252A1 (en) | 2000-11-23 |
JP2003500341A (en) | 2003-01-07 |
JP2008110986A (en) | 2008-05-15 |
CN101289500A (en) | 2008-10-22 |
CA2373252C (en) | 2007-08-07 |
TWI300414B (en) | 2008-09-01 |
JP4209086B2 (en) | 2009-01-14 |
WO2000070665A2 (en) | 2000-11-23 |
JP2009143941A (en) | 2009-07-02 |
SM200000031A (en) | 2001-11-21 |
ZA200109110B (en) | 2002-06-13 |
CN1698881A (en) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA51899A (en) | handstamp | |
NO20005890D0 (en) | Antiangiogenic peptide drugs | |
DE50001455D1 (en) | BLISTER | |
DE59905215D1 (en) | A hemming | |
DE60038157D1 (en) | CONSTRUCTION MACHINE | |
DE50005126D1 (en) | Circular comb-set | |
DE10084333T1 (en) | Efficient microprocessor architecture | |
SM200000031B (en) | Prolonged effect antiangiogenic peptides | |
DE60034297D1 (en) | switch arrangement | |
NO991727D0 (en) | A material | |
DE50010867D1 (en) | covering | |
FR2802198B1 (en) | INDIVIDUAL SECTIONS MACHINE | |
NO20013933D0 (en) | peptides | |
DE59905747D1 (en) | blister | |
ATA121799A (en) | AUSBEULGERÄT | |
DE59913434D1 (en) | switch | |
DE60020365D1 (en) | ACIDICATED IMPROVEMENTS | |
ATA107599A (en) | HEIZWASSERBEREITER | |
FI4404U1 (en) | A connection piece | |
NO20013625L (en) | Megsinpromotor | |
IT247019Y1 (en) | GAUZING MACHINE | |
FR2797145B1 (en) | IMPROVED FLOOR-MIXER-DISPENSING MACHINE | |
DE50005638D1 (en) | covering | |
IT1314348B1 (en) | GENERATOR-DESALINATOR MACHINE | |
IT1309270B1 (en) | DEPALLETISING MACHINE |